Vaccination

Moderna announced positive interim results from a phase 3 trial of its next-generation COVID-19 vaccine, which the company said will help pave the way for its combination shot against COVID-19 and influenza.

The FDA approved Xhance for the treatment of chronic rhinosinusitis without nasal polyps among patients aged 18 years and older.

Use of an influenza vaccine messaging platform in EDs increased vaccine uptake among unvaccinated patients, a study in NEJM Evidence showed.

A task force supported by the Pediatric Infectious Diseases Society recently published the first guidance for the prevention and treatment of COVID-19 in children in the vaccine era.

WASHINGTON — Children with primary immunodeficiencies should receive routine inactive vaccinations and other prophylactic treatment, according to a presentation at the American Academy of Allergy, Asthma & Immunology Annual Meeting.

WASHINGTON — Children taking dupilumab for atopic diseases received measles, mumps and rubella and varicella immunizations later than other children, according to a poster presented here.

DENVER — Among people with HIV, hybrid immunity against COVID-19 is more effective at preventing infection and severe disease than vaccination alone, according to a study.

A “rapid response to hepatitis A exposure” helped minimize the risk for transmission and prevent an HAV outbreak among incarcerated persons in a Los Angeles County jail, according to an investigation in Morbidity and Mortality Weekly Report.

Personalized care could help patients and providers plan safe returns to work or school from respiratory illnesses, according to a research review.

Regardless of vaccination status, individuals with hematologic malignancies had increased odds of developing severe COVID-19 until oral antivirals became widely available in mid-2022, according to data published in JAMA Network Open.